Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Arch Toxicol ; 95(1): 345-353, 2021 01.
Artigo em Inglês | MEDLINE | ID: mdl-32880718

RESUMO

Snakebite envenomation causes > 81,000 deaths and incapacities in another 400,000 people worldwide every year. Snake venoms are complex natural secretions comprised of hundreds of different molecules with a wide range of biological functions that after injection cause local and systemic manifestations. Although several studies have investigated snake venoms, the majority have focused on the protein portion (toxins), without significant attention paid to the lipid fraction. Therefore, an untargeted lipidomic approach based on liquid chromatography with high-resolution mass spectrometry (LC-HRMS) was applied to investigate the lipid constituents of venoms of the snake species Crotalus durissus terrificus and Bothrops moojeni. Phosphatidylcholines (PC), Lyso-PCs, phosphatidylethanolamines (PE), Lyso-PE, phosphatidylserine (PS), phosphatidylinositol (PI), ceramides (Cer), and sphingomyelin (SM) species were detected in the analyzed snake venoms. The identified lipids included bioactive compounds such as platelet-activating factor (PAF) precursor, PAF-like molecules, plasmalogens, ceramides, and sphingomyelins with long fatty acid chain lengths, which may be associated with the systemic responses triggered by C. d. terrificus and B. moojeni envenomation. These responses include platelet aggregation, activation of intercellular adhesion molecule 1 (ICAM1), apoptosis, as well as the production of pro-inflammatory lipid mediators, cytokines, and reactive species. The newly proposed lipidomics strategy provided valuable information regarding the lipid profiles of viperid venoms, which could lead to increased understanding of the complex pathology promoted by snakebite envenomation.


Assuntos
Bothrops , Ceramidas/metabolismo , Venenos de Crotalídeos/metabolismo , Crotalus , Lipidômica , Fosfolipídeos/metabolismo , Mordeduras de Serpentes , Esfingomielinas/metabolismo , Animais , Ceramidas/toxicidade , Cromatografia Líquida de Alta Pressão , Venenos de Crotalídeos/toxicidade , Fosfolipídeos/toxicidade , Esfingomielinas/toxicidade , Espectrometria de Massas em Tandem
2.
J Cardiovasc Pharmacol ; 61(2): 160-5, 2013 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-23222311

RESUMO

Atherosclerosis is a major cause of death in the Western World. It is known that Lipofundin 20% induces atherosclerotic lesions, whereas ozone at low doses has been satisfactorily used in the prevention of oxidative stress-associated pathologies, such as coronary artery diseases. The aim of the present work was to evaluate the effects of ozone therapy on Lipofundin-induced atherosclerotic lesions in New Zealand White rabbits. Ozone (1 mg), mixed with oxygen as passive carrier, was administered by rectal insufflation during 15 sessions in 5 weeks. Then, the animals were intravenously treated with 2 mL/kg of Lipofundin, daily during 8 days. Animals were euthanized and eosin and hematoxylin staining was used for aortic histopathological analysis. The biomarkers of oxidative stress and lipid profile in serum were determined by spectrophotometric techniques. The results demonstrated that ozone induced inhibitory effects on aortic lesions formation. On the other hand, a reduction of biomolecular damage and an increase of antioxidant systems were observed at the end of the experiment. The serum lipids profiles were not modified after only 1 cycle of ozone treatment. Our results reinforced the hypotheses that antioxidant effects induced by ozone in the context of atherosclerosis demonstrate the antiatherogenic properties of the gas in the experimental conditions of this study.


Assuntos
Antioxidantes/farmacologia , Aterosclerose/prevenção & controle , Estresse Oxidativo/efeitos dos fármacos , Ozônio/farmacologia , Animais , Antioxidantes/administração & dosagem , Antioxidantes/metabolismo , Aorta/efeitos dos fármacos , Aorta/patologia , Modelos Animais de Doenças , Combinação de Medicamentos , Lipídeos/sangue , Masculino , Oxigênio/administração & dosagem , Ozônio/administração & dosagem , Fosfolipídeos/toxicidade , Coelhos , Sorbitol/toxicidade , Espectrofotometria
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA